168 related articles for article (PubMed ID: 22935246)
1. Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice.
Rivera J; Rejas-Gutiérrez J; Vallejo MA; Esteve-Vives J; De Salas-Cansado M;
Clin Exp Rheumatol; 2012; 30(6 Suppl 74):31-8. PubMed ID: 22935246
[TBL] [Abstract][Full Text] [Related]
2. Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain.
Rivera J; Rejas J; Esteve-Vives J; Vallejo MA;
Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S39-45. PubMed ID: 20074438
[TBL] [Abstract][Full Text] [Related]
3. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
White LA; Birnbaum HG; Kaltenboeck A; Tang J; Mallett D; Robinson RL
J Occup Environ Med; 2008 Jan; 50(1):13-24. PubMed ID: 18188077
[TBL] [Abstract][Full Text] [Related]
4. The costs associated with sleep symptoms among patients with fibromyalgia.
Wagner JS; Chandran A; DiBonaventura M; Cappelleri JC
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):131-9. PubMed ID: 23402453
[TBL] [Abstract][Full Text] [Related]
5. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.
Chandran A; Schaefer C; Ryan K; Baik R; McNett M; Zlateva G
J Manag Care Pharm; 2012; 18(6):415-26. PubMed ID: 22839682
[TBL] [Abstract][Full Text] [Related]
6. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.
Winkelmann A; Perrot S; Schaefer C; Ryan K; Chandran A; Sadosky A; Zlateva G
Appl Health Econ Health Policy; 2011 Mar; 9(2):125-36. PubMed ID: 21332254
[TBL] [Abstract][Full Text] [Related]
7. Resource utilisation and direct costs in patients with recently diagnosed fibromyalgia who are offered one of three different interventions in a randomised pragmatic trial.
van Eijk-Hustings Y; Kroese M; Creemers A; Landewé R; Boonen A
Clin Rheumatol; 2016 May; 35(5):1307-15. PubMed ID: 26409883
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of irritable bowel syndrome in China.
Zhang F; Xiang W; Li CY; Li SC
World J Gastroenterol; 2016 Dec; 22(47):10450-10460. PubMed ID: 28058026
[TBL] [Abstract][Full Text] [Related]
9. Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia.
White LA; Robinson RL; Yu AP; Kaltenboeck A; Samuels S; Mallett D; Birnbaum HG
J Pain; 2009 Sep; 10(9):976-83. PubMed ID: 19556168
[TBL] [Abstract][Full Text] [Related]
10. Economic cost and epidemiological characteristics of patients with fibromyalgia claims.
Robinson RL; Birnbaum HG; Morley MA; Sisitsky T; Greenberg PE; Claxton AJ
J Rheumatol; 2003 Jun; 30(6):1318-25. PubMed ID: 12784409
[TBL] [Abstract][Full Text] [Related]
11. Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains.
Perrot S; Schaefer C; Knight T; Hufstader M; Chandran AB; Zlateva G
BMC Musculoskelet Disord; 2012 Feb; 13():22. PubMed ID: 22340435
[TBL] [Abstract][Full Text] [Related]
12. The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States.
Schaefer C; Mann R; Masters ET; Cappelleri JC; Daniel SR; Zlateva G; McElroy HJ; Chandran AB; Adams EH; Assaf AR; McNett M; Mease P; Silverman S; Staud R
Pain Pract; 2016 Jun; 16(5):565-79. PubMed ID: 25980433
[TBL] [Abstract][Full Text] [Related]
13. A higher score on the dermatology life quality index, being on systemic treatment and having a diagnosis of psoriatic arthritis is associated with increased costs in patients with plaque psoriasis.
Ekelund M; Mallbris L; Qvitzau S; Stenberg B
Acta Derm Venereol; 2013 Nov; 93(6):684-8. PubMed ID: 23603935
[TBL] [Abstract][Full Text] [Related]
14. Cost comparison of adding pregabalin or gabapentin for the first time to the therapy of patients with painful axial radiculopathy treated in Spain.
Sicras-Mainar A; Rejas-Gutiérrez J; Navarro-Artieda R; Planas-Comes A
Clin Exp Rheumatol; 2013; 31(3):372-81. PubMed ID: 23432967
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of Spa treatment for fibromyalgia: general health improvement is not for free.
Zijlstra TR; Braakman-Jansen LM; Taal E; Rasker JJ; van de Laar MA
Rheumatology (Oxford); 2007 Sep; 46(9):1454-9. PubMed ID: 17636181
[TBL] [Abstract][Full Text] [Related]
16. Burden of fibromyalgia and comparisons with osteoarthritis in the workforce.
Kleinman N; Harnett J; Melkonian A; Lynch W; Kaplan-Machlis B; Silverman SL
J Occup Environ Med; 2009 Dec; 51(12):1384-93. PubMed ID: 19952796
[TBL] [Abstract][Full Text] [Related]
17. The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis.
Silverman S; Dukes EM; Johnston SS; Brandenburg NA; Sadosky A; Huse DM
Curr Med Res Opin; 2009 Apr; 25(4):829-40. PubMed ID: 19220165
[TBL] [Abstract][Full Text] [Related]
18. Healthcare costs and productivity losses directly attributable to ankylosing spondylitis.
Rafia R; Ara R; Packham J; Haywood KL; Healey E
Clin Exp Rheumatol; 2012; 30(2):246-53. PubMed ID: 22409861
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin.
Gore M; Sadosky AB; Zlateva G; Clauw DJ
Pain Pract; 2009; 9(5):363-74. PubMed ID: 19500273
[TBL] [Abstract][Full Text] [Related]
20. [Impact of morbidity, resource use and costs on maintenance of remission of major depression in Spain: a longitudinal study in a population setting].
Sicras-Mainar A; Blanca-Tamayo M; Gutiérrez-Nicuesa L; Salvatella-Pasant J; Navarro-Artieda R
Gac Sanit; 2010; 24(1):13-9. PubMed ID: 19646795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
